MedTrace Logo

The Effect of Esketamine on Sleep Disturbance

NCT06388824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2025-02-12

No results posted yet for this study

Summary

To explore the efficacy of a single low dose of esketamine during surgical abortion in patients with sleep disturbance

Conditions

  • Sleep Disturbance

Interventions

DRUG

normal saline

Patients undergoing surgical abortion received a single injection of 5ml 0.9% normal saline after the beginning of surgery

DRUG

Esketamine

Patients undergoing surgical abortion received a single injection of 0.2mg/kg esketamine after the beginning of surgery

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    lead OTHER

Principal Investigators

  • Guolin Wang, MD, PhD · Tianjin Medical University General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-03
Primary Completion
2024-11-07
Completion
2024-11-13

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06388824 on ClinicalTrials.gov